Salud mental, trastorno por uso de sustancias y trastorno por uso de opioides: actualizaciones y estrategias de tratamiento
DOI:
https://doi.org/10.11606/issn.1806-6976.smad.2021.187412Palabras clave:
Trastornos relacionados con sustancias, Trastornos relacionados con opioides, Salud mental, TerapéuticaResumen
Objetivo: describir las principales estrategias para abordar las brechas en la identificación, tratamiento y capacitación en salud mental, trastorno por uso de sustancias (TUS) y trastorno por uso de opioides (TUO). Método: se trata de una revisión narrativa, basada en artículos y publicaciones recientes de instituciones reconocidas internacionalmente que abordan el tema de la salud mental y la dependencia química. Resultados: la prevalencia del uso concomitante de sustancias y trastornos psiquiátricos/de salud mental ha sido alta y continúa creciente, lo que agrava problemas complejos que implican desafíos de tratamiento multifacéticos, que incluyen afecciones médicas, discapacidades, falta de vivienda, abandono del uso de medicaciones y elevadas tasas de recaída. El tratamiento de los TUS y TUO son problemas individualmente complejo. Una combinación de los dos requiere un enfoque de diagnóstico y tratamiento dedicado y multifacético.
Conclusión: como la prevalencia de TUO, TUS y COD sigue aumentando, las enfermeras y los profesionales de la salud deben estar preparados para diagnosticar, tratar y / o encaminar para
garantizar la atención adecuada y la recuperación a largo plazo de las personas afectadas.
Descargas
Referencias
Substance Abuse and Mental Health Services Administration (US). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55) [Internet]. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2020. [cited 2021 June 10]. Available from: https://www.samhsa.gov/data/
Gordon S. About a Revolution: Toward Integrated Treatment in Drug and Mental Health Courts [Internet]. 2019 [cited 2021 June 10].
Available from: https://scholars.law.unlv.edu/facpub/1179
Mota P. Avoiding a new epidemic during a pandemic: The importance of assessing the risk of substance use disorders in the COVID-19 era. Psychiatry Res. 2020;290:113142. doi: https://doi.org/10.1016/j.psychres.2020.113142
Milano G, Vergani HM, Cattedra S, Carrozzino R, Mattioli F, Robbiano L, et al. Co-Occurring Psychiatric and Substance Use Disorders: Clinical Survey Among a Rural Cohort of Italian Patients. Neuropsychiatr Dis Treat. 2019;15:3453-9. doi: https://doi.org/10.2147/NDT.S222567
American Medical Association (US). Drug overdose epidemic worsened during COVID pandemic [Internet]. Maryland: AMA; 2020. [cited 2021 June 10]. Available from: https://www.ama-assn.org/system/files/2020-11/issue-brief-increases-in-opioid-related-overdose.pdf
Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD. Treatment Access Barriers and Disparities Among Individuals with Co-Occurring Mental Health and Substance Use Disorders: An Integrative Literature Review. J Subst Abuse Treat. 2016;61:47-59. doi: https://doi.org/10.1016/j.jsat.2015.09.006
Ritchie H, Roser M. Drug use [Internet]. 2019 [cited 2021 June 10]. Available from: https://ourworldindata.org/drug-use
American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: APA; 2013.
Centers for Disease Control and Prevention (US). Opioid Overdose. Washington, D.C.: CDC; 2020 [cited 2021 June 18]. Available from: https://www.cdc.gov/drugoverdose/epidemic/index.html#:~:text=The%20first%20wave%20began%20with,increasing%20since%20at%20least%201999.&text=The%20second%20wave%20began%20in,in%20overdose%20deaths%20involving%20heroin
Velez FF, Luderer HF, Gerwien R, Parcher B, Mezzio D, Malone DC. Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder. Postgrad Med. 2021;133(4):421-7. doi: https://doi.org/10.1080/00325481.2021.1884471
Schulte M, Boumparis N, Huizink AC, Riper H. Technological Interventions for the Treatment of Substance Use Disorders. Ref Mod Neurosci Biobehav Psychol. 2020. doi: https://doi.org/10.1016/B978-0-12-818697-8.00010-8
Stoychev KR. Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings. Front Psychiatry. 2019;10:702. doi: https://doi.org/10.3389/fpsyt.2019.00702
Substance Abuse and Mental Health Services Administration (US). Women in the mirror: Addressing co-occurring mental health issues and trauma in women with substance use disorders [Internet]. Rockville, MD: SAMHSA; 2015 [cited 2021 June 13]. Available from: https://www.samhsa.gov/sites/default/fles/programs_ campaigns/women_children_families/women-in-mirror.pdf
Substance Abuse and Mental Health Services Administration; Office of the Surgeon General (US). Early Intervention, Treatment, and Management of Substance Use Disorders. In: Substance Abuse and Mental Health Services Administration; Office of the Surgeon General (US). Facing addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health [Internet]. Washington, D.C.: US Department of Health and Human Services; 2016 [cited 2021 June 13]. Chap. 4. Available from: https://www.ncbi.nlm.nih.gov/books/NBK424859/
Jones EB, Staab EM, Wan W, Quinn MT, Schaefer C, Gedeon S, et al. Addiction Treatment Capacity in Health Centers: The Role of Medicaid Reimbursement and Targeted Grant Funding. Psychiatr Serv. 2020;71(7):684-90. doi: https://doi.org/10.1176/appi.ps.201900409
Hadjikou A, Pavlopoulou ID, Pantavou K, Georgiou A, Williams LD, Christaki E, et al. Drug Injection-Related Norms and High-Risk Behaviors of People Who Inject Drugs in Athens, Greece. AIDS Res Hum Retroviruses. 2021;37(2):130-8. doi: http://doi.org/10.1089/aid.2020.0050
Guerrieri M, Giacomini PG, Flora B, Silvani L, Di Girolamo S. Drug-Induced Atrophic Rhinitis. In: Di Girolamo S, editor. Atrophic Rhinitis. Cham: Springer; 2020. doi: https://doi.org/10.1007/978-3-030-51705-2_4
Mukherji P, Azhar Y, Sharma S. Toxicology Screening [Internet]. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2020 [cited 2021 June 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499901/
Beck O. Exhaled breath for drugs of abuse testing: evaluation in criminal justice settings. Sci Justice. 2014;54(1):57-60. doi: http://doi.org/10.1016/j.scijus.2013.09.007
Moeller KE, Kissack JC, Atayee RS, Lee KC. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens. Mayo Clin Proc. 2017;92(5):774-96. doi: https://doi.org/10.1016/j.mayocp.2016.12.007
Yang YK, Johnson-Davis KL, Kelly BN, McMillin GA. Demand for Interpretation of a Urine Drug Testing Panel Reflects the Changing Landscape of Clinical Needs; Opportunities for the Laboratory to Provide Added Clinical Value. J Appl Lab Med. 2020;5(5):858-68. doi: https://doi.org/10.1093/jalm/jfaa119
Xue W, Tan X, Khaing Oo MK, Kulkarni G, Ilgen MA, Fan X. Rapid and sensitive detection of drugs of abuse in sweat by multiplexed capillary based immuno-biosensors. Analyst. 2020;145(4):1346-54. doi: https://doi.org/10.1039/c9an02498k
OraSure. Oral fluid test [Internet]. 2015. [cited 2021 June 17]. Available from: http://www.orasure.com/products-substance/products-substance-abuse-intercept-FAQ.asp
Kimmel SD, Bazzi AR, Barocas JA. Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities. J Subst Abuse Treat. 2020;118:108103. doi: https://doi.org/10.1016/j.jsat.2020.108103
Hyshka E, Morris H, Anderson-Baron J, Nixon L, Dong K, Salvalaggio G. Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital. Drug Alcohol Depend. 2019;204:107523. doi: https://doi.org/10.1016/j.drugalcdep.2019.06.025
Adams JM, Volkow ND. Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders. AMA J Ethics. 2020;22(1):E702-8. doi: https://doi.org/10.1001/amajethics.2020.702
National Institute of Drug Abuse (NIDA) (US). Why is there comorbidity between substance use disorders and mental illnesses? [Internet]. 2020 [cited 2021 June 13]. Available from: https://www.drugabuse.gov/publications/research-reports/common-comorbidities-substance-use-disorders/why-there-comorbidity-between-substance-use-disorders-mental-illnesses
Wakeman SE. Facing Addiction. Psychiatr Ann. 2019;49(2):47-54. doi: https://doi.org/10.3928/00485713-20190108-01
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (US). Treatment Episode Data Set (TEDS): 2017. Admissions to and discharges from publicly funded substance use treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019.
Kelly PJ, Baker AL, Deane FP, Callister R, Collins CE, Oldmeadow C, et al. Study protocol: A stepped wedge cluster randomised controlled trial of a healthy lifestyle intervention for people attending residential substance abuse treatment. BMC Public Health. 2015;465(2015). doi: https://doi.org/10.1186/s12889-015-1729-y
DiClemente CC, Corno CM, Graydon MM, Wiprovnick AE, Knoblach DJ. Motivational interviewing, enhancement, and brief interventions over the last decade: A review of reviews of efficacy and effectiveness. Psychol Addict Behav. 2017;31(8):862-87. doi: https://doi.org/10.1037/adb0000318
- Solari CD, Shivji A, de Sousa T, Watt R, Silverbush M, Khadduri J, et al. The 2016 annual homeless assessment report (AHAR) to Congress. Part 2: Estimates of homelessness in the United States [Internet]. Washington, D.C.: United States Department of Housing and Urban Development; 2017. [cited 2021 June 13]. Available from: http://works.bepress.com/dennis_culhane/214/
Tsai J, Cao X. Association between suicide attempts and homelessness in a population-based sample of US veterans and non-veterans. J Epidemiol Community Health. 2019;73(4):346-52. doi: https://doi.org/10.1136/jech-2018-211065
Fazel S, Yoon IA, Hayes AJ. Substance use disorders in prisoners: an updated systematic review and meta-regression analysis in recently incarcerated men and women. Addiction. 2017;112(10):1725-39. doi: https://doi.org/10.1111/add.13877
Al-Rousan T, Rubenstein L, Sieleni B, Deol H, Wallace RB. Inside the nation's largest mental health institution: a prevalence study in a state prison system. BMC Public Health. 2017;17(1):342. doi: https://doi.org/10.1186/s12889-017-4257-0
Evans E, Padwa H, Li L, Lin V, Hser YI. Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment. J Subst Abuse Treat. 2015;59:10-9. doi: https://doi.org/10.1016/j.jsat.2015.06.021
Maura J, Weisman de Mamani A. Mental Health Disparities, Treatment Engagement, and Attrition Among Racial/Ethnic Minorities with Severe Mental Illness: A Review. J Clin Psychol Med Settings. 2017;24(3-4):187-210. doi: https://doi.org/10.1007/s10880-017-9510-2
Mauro PM, Canham SL, Martins SS, Spira AP. Substance-use coping and self-rated health among US middle-aged and older adults. Addict Behav. 2015;42:96-100. doi: https://doi.org/10.1016/j.addbeh.2014.10.03
Bush DM, Lipari RN. Substance Use and Substance Use Disorder by Industry [Internet]. In: The CBHSQ Report. Rockville, MD; Substance Abuse and Mental Health Services Administration; 2013. [cited 2021 June 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK343542/
Jordan TR, Khubchandani J, Wiblishauser M. The Impact of Perceived Stress and Coping Adequacy on the Health of Nurses: A Pilot Investigation. Nurs Res Pract. 2016;2016:5843256. doi: https://doi.org/10.1155/2016/5843256
Kunyk D. Substance use disorders among registered nurses: prevalence, risks and perceptions in a disciplinary jurisdiction. J Nurs Manag. 2015;23(1):54-64. doi: https://doi.org/10.1111/jonm.12081
Winkler A. Treating Physicians for Addiction. Am J Psychiatry Res J. 2017;12(4):6-7. doi: https://doi.org/10.1176/appi.ajp-rj.2017.1204037.120403
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2021 SMAD Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português)
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
